Overview

BIOLASE Technology develops and markets advanced medical and dental laser products, including specialized biomaterials for medical and other dentistry specialties. BIOLASE products incorporate new patented and patent-pending technologies that achieve results not available through other products. 

BIOLASE is the manufacturer of dentistry's #1 selling Waterlase® YSGG dental laser.

History

BIOLASE Technology is the successor to a company founded in 1986 to develop and market laser products. In 1991, the company began developing and shipping laser-based dental systems. With the introduction of the Waterlase® cutting system in 1996, BIOLASE began to reposition itself to capitalize on the newer, innovative technologies in the marketplace. The Waterlase employs patented HydroPhotonics™ tissue cutting technology that combines YSGG laser energy and water. The company phased out its traditional dental laser systems in 1996.

Headquarters

The BIOLASE headquarters are located in Irvine, California. BIOLASE's in-house design and manufacturing facilities are state-of-the-art and FDA and Good Manufacturing Practice (GMP) compliant.

Advantages of in-house design and manufacturing include:

• quality control
• protecting proprietary technology
• controlling costs
• managing manufacturing changes

Market Overview

Lasers are widely used in a variety of medical fields such as ophthalmology, gynecology, urology, dermatology, otolaryngology (ear, nose, throat), gastrointestinal tract ailments, and cosmetic and general surgeries. In many applications, lasers have become preferred method of treatment. In October 1998, the Food and Drug Administration (FDA) cleared BIOLASE's HYDROPHOTONIC laser for hard tissue dental procedures.  Along with previous clearance for soft tissue procedures, BIOLASE believes that this unique patented HYDROKINETICT laser cutting technology can become the standard for hard and soft tissue cutting instruments.

BIOLASE's products are designed to elevate
the worldwide standard of medical and dental care. The Company addresses the tissue heating problem of traditional laser systems on hard tissue cutting procedures by developing its innovative Target Tissue CoolingT system (TTCT). This breakthrough should allow for the advanced use of lasers in many medical areas and holds tremendous potential for the dental, orthopedic, cosmetic, dermatological, and neurosurgical markets.

The BIOLASE Code of Conduct and Business Ethics

BIOLASE's reputation is our greatest asset. We recognize that the value of our reputation depends on the character of our employees, so we follow a strict Code of Conduct. To review the BIOLASE Code of Conduct CLICK HERE